
Charlotte Boughton
@ckboughton
Clinical researcher in closed-loop technology for people with diabetes
ID: 942706010573168640
18-12-2017 10:40:02
221 Tweet
335 Followers
355 Following


The Banting Memorial Lecture stephen o'rahilly (its pronounced O-RA-hill-EEE) remembers the late Prof David Dunger as he introduces the wonderful @_RomanHovorka to share his phenomenal work on Closed Loop #DUKPC 2924


Celebrating @_RomanHovorka great work & Diabetes UK Banting Lecture Mark Evans Diabetes UK @JDRF @JDRFUK stephen o'rahilly (its pronounced O-RA-hill-EEE) Sara hartnell @wilinska_ma Julia Ware (nee Fuchs) Nithya Kad and Prof Murphy


Great to see the James Lind Alliance refresh for Cystic Fibrosis getting a shout out from @Paula_Sommer at #CFGI24. Research priorities for CF jointly agreed by people with CF and clinicians. cf/Aware Question CF Cystic Fibrosis Trust Cystic Fibrosis Foundation



Our latest review on automated insulin delivery systems is now online! rdcu.be/dHSqP @_RomanHovorka Diabetologia Inst Metabolic Science-Metabolic Research Labs




📢 Check out the international consensus guidance for monitoring autoantibody-positive individuals in early-stage type 1 diabetes. FREE to Read 🔗 diabetesjournals.org/care/lookup/do… ADA Professional Publications American Diabetes Association American Diabetes Association - DiabetesPro Diabetologia Moshe Phillip



New article online now in Diabetologia : link.springer.com/article/10.100… We wanted to study if kidney #transplant candidates with #diabetes have equitable transplantation opportunities or have divergent survival probabilities stratified by kidney replacement therapy.


A #precisionmentalhealth study identified individual contributors to diabetes distress using n-of-1 analyses. Overall, interpretation of glucose values is more important for distress than actual glucose values.Dominic Ehrmann, funded by Deutsches Zentrum für Diabetesforschung (DZD) tinyurl.com/64hfjyae 🔓







Original Article: A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes (2IQP trial) nej.md/4ioCwR2 #ATTD2025 | Advanced Technologies & Treatments for Diabetes
